Insider filing · MLTX
Matthias Bodenstedt
Chief Financial Officer
profile →
MoonLake Immunotherapeutics
MLTX · Healthcare · 18 filings in 24 months
ticker →
Matthias Bodenstedt sold $1.6M of MoonLake Immunotherapeutics (MLTX)
Executed Apr 9, disclosed Apr 10, 1 day later.
Value, as filed
$1.6M
85,870 sh × $18.94
Executed
Apr 9
the trade date, as filed
Disclosed
Apr 10
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MBMatthias Bodenstedt (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $1.6M of MLTX (85,870 sh × $18.94, as filed), executed Apr 9.
The name
MLTXHealthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Matthias Bodenstedt in MLTX
MLTXSALE
MoonLake Immunotherapeutics
$862K39,120 sh × $22.04
Exec Jun 22
Filed Jun 23 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics $297K
15,082 sh × $19.68
Exec Jun 17
Filed Jun 18 · 5:30 PM ET MLTXSALE MoonLake Immunotherapeutics $273K
13,653 sh × $20.02
Exec May 11
Filed May 13 · 5:30 PM ET